TREA

88607972 - PALSAR

Follow

Information

  • Trademark
  • 88607972
  • Serial Number
    88607972
  • Registration Number
    7215616
  • Filing Date
    September 06, 2019
    6 years ago
  • Registration Date
    November 14, 2023
    a year ago
  • Transaction Date
    November 14, 2023
    a year ago
  • Status Date
    November 14, 2023
    a year ago
  • Published for Opposition Date
    January 03, 2023
    2 years ago
  • Location Date
    November 14, 2023
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HERRERA-MARCUS, ROSELL
  • Attorney Docket Number
    7T19719416
    Attorney Name
    Boris Umansky
    Law Office Assigned Location Code
    N60
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
PALSAR
Case File Statements
  • GS0011: Nucleic acid sequences as reagents for use in genetic research, other than for medical or veterinary purposes; nucleic acids for scientific purposes, chemical compositions and materials in the nature of chemicals for use in genotyping, all as chemicals for use in industry; reagents, enzymes, chemical compositions, chemical primers and chemical probes for use in the manufacture of pharmaceuticals; biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; nucleic acid sequences known as probes for use in signal amplification for use in the manufacture of diagnostic reagents for scientific or medical research use; nucleic acid sequences known as probes for use in signal amplification techniques for use in the pharmaceutical industry; nucleic acid sequences known as probes for use in detecting nucleic acids for raw material in the manufacture of pharmaceuticals; nucleic acid sequences known as probes for use in detecting mRNA directly without synthesizing cDNA for use as a raw material in the manufacture of diagnostic reagents; nucleic acid sequences known as probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use as a raw material in the manufacture of diagnostic reagents for scientific or research use; nucleic acid sequences known as probes for use in forming self-assembly honeycomb structure for use as an ingredient in pharmaceuticals; nucleic acid sequences known as probes for use in quantifying intact drug and parent drug fragment for use as an ingredient in diagnostic reagents; nucleic acid sequences known as probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for an ingredient in diagnostic reagents for scientific or medical research; nucleic acid sequences known as probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for as diagnostic reagents for scientific or medical research use; nucleic acid sequences known as probes for use in quantifying using samples from blood, tissue and cell lysates for use in cell cultures other than for medical or veterinary use; nucleic acid sequences known as probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for diagnostic reagents and preparations, except for medical or veterinary use; nucleic acid sequences known as probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes for use in self-assembly reactions for as reagents for use in industry utilizing technology of DNA self-assembly reactions; nucleic acid sequences known as probes to be used as signal amplifier for use in industry to detect nucleic acids; nucleic acid sequences known as probes for use in analyzing samples without using PCR for use in industry to detect mRNAs; biochemical reagents commonly known as probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; biochemical reagents commonly known as probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; biotin labeled honeycomb probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; honeycomb probes to which biotins are labeled for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; A short DNA probe pair for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; self-assembled DNA probes for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; probes made by DNA self-assembly reactions for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in signal amplification for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in signal amplification techniques for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in detecting nucleic acids for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in detecting mRNA directly without synthesizing cDNA for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in multiplex detection of mRNAs simultaneously in a single tube reaction for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in forming self-assembly honeycomb structure for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying intact drug and parent drug fragment for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying intact drug and parent drug fragment at picogram-nanogram levels for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying parent and fragments with only 1-2 mers difference for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in measuring analytes directly from matrix without using highly purified nucleic acid or reverse transcriptase reaction for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in quantifying using samples from blood, tissue and cell lysates for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in simultaneously quantifying heteroduplex oligonucleotide drugs for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in analyzing samples using bioanalytical methods for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in self-assembly reactions for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier to be used as signal amplifier for use in industry utilizing technology of DNA self-assembly reactions; A signal amplifier for use in analyzing samples without using PCR for use in industry utilizing technology of DNA self-assembly reactions; self-assembly formed by a short DNA probe pair for use in industry utilizing technology of DNA self-assembly reactions
Case File Event Statements
  • 11/14/2023 - a year ago
    65 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 11/14/2023 - a year ago
    64 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/12/2023 - 2 years ago
    63 - 1(B) BASIS DELETED; PROCEED TO REGISTRATION Type: DP1B
  • 8/28/2023 - 2 years ago
    62 - NOTICE OF ALLOWANCE CANCELLED Type: IUCN
  • 8/28/2023 - 2 years ago
    61 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 2/28/2023 - 2 years ago
    60 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 1/3/2023 - 2 years ago
    59 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/3/2023 - 2 years ago
    58 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/14/2022 - 2 years ago
    57 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 11/28/2022 - 2 years ago
    56 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/25/2022 - 2 years ago
    55 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/25/2022 - 2 years ago
    54 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/25/2022 - 2 years ago
    53 - ASSIGNED TO LIE Type: ALIE
  • 9/19/2022 - 3 years ago
    52 - ASSIGNED TO LIE Type: ALIE
  • 9/14/2022 - 3 years ago
    51 - ASSIGNED TO LIE Type: ALIE
  • 9/6/2022 - 3 years ago
    50 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 3/31/2022 - 3 years ago
    49 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 3/31/2022 - 3 years ago
    48 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 3/31/2022 - 3 years ago
    47 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 3/21/2022 - 3 years ago
    46 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/21/2022 - 3 years ago
    45 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/10/2022 - 3 years ago
    44 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 9/13/2021 - 4 years ago
    43 - SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION Type: RCCK
  • 9/10/2021 - 4 years ago
    42 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 9/10/2021 - 4 years ago
    41 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 9/10/2021 - 4 years ago
    40 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 2/4/2021 - 4 years ago
    39 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 2/4/2021 - 4 years ago
    38 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 2/4/2021 - 4 years ago
    37 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 2/3/2021 - 4 years ago
    36 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 2/3/2021 - 4 years ago
    35 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 2/3/2021 - 4 years ago
    34 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 2/3/2021 - 4 years ago
    33 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 8/4/2020 - 5 years ago
    32 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 8/4/2020 - 5 years ago
    31 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 8/4/2020 - 5 years ago
    30 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/16/2020 - 5 years ago
    29 - DIVISIONAL PROCESSING COMPLETE Type: DPCC
  • 6/8/2020 - 5 years ago
    28 - DIVISIONAL REQUEST RECEIVED Type: DRRR
  • 7/15/2020 - 5 years ago
    27 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/15/2020 - 5 years ago
    26 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/15/2020 - 5 years ago
    25 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/1/2020 - 5 years ago
    24 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/1/2020 - 5 years ago
    23 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/1/2020 - 5 years ago
    22 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/24/2020 - 5 years ago
    21 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 6/24/2020 - 5 years ago
    20 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 6/24/2020 - 5 years ago
    19 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 6/24/2020 - 5 years ago
    18 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 6/24/2020 - 5 years ago
    17 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 6/24/2020 - 5 years ago
    16 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/16/2020 - 5 years ago
    15 - ASSIGNED TO LIE Type: ALIE
  • 6/8/2020 - 5 years ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/8/2020 - 5 years ago
    13 - TEAS REQUEST TO DIVIDE RECEIVED Type: ERTD
  • 1/30/2020 - 5 years ago
    12 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/30/2020 - 5 years ago
    11 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/28/2020 - 5 years ago
    10 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/28/2020 - 5 years ago
    9 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 12/6/2019 - 5 years ago
    8 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/6/2019 - 5 years ago
    7 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/6/2019 - 5 years ago
    6 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/23/2019 - 5 years ago
    5 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/23/2019 - 6 years ago
    4 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/11/2019 - 6 years ago
    3 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Type: TAEA
  • 9/11/2019 - 6 years ago
    2 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 9/10/2019 - 6 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP